Journal article
In high-risk outpatients with COVID-19, remdesivir reduced COVID-19-related hospitalization or all-cause death at 28 d.
Abstract
SOURCE CITATION: Gottlieb RL, Vaca CE, Paredes R, et al. Early remdesivir to prevent progression to severe Covid-19 in outpatients. N Engl J Med. 2022;386:305-15. 34937145.
Authors
Mourad O; Chagla Z
Journal
Annals of Internal Medicine, Vol. 175, No. 5,
Publisher
American College of Physicians
Publication Date
May 2022
DOI
10.7326/j22-0026
ISSN
1056-8751